Respiratory syncytial virus (RSV) is a common respiratory virus which disproportionally affects new-borns and infants.

The 2025-2026 respiratory viral season is approaching.With it comes the familiar challenge of protecting our most vulnerable ...

Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the ...

As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid ...

The respiratory syncytial virus vaccine is effective in reducing emergency visits, hospitalizations, and severe illness in ...

Respiratory syncytial virus can cause severe illness especially in young infants. A new study published in Eurosurveillance ...

A new study shows that the effectiveness of current vaccines against porcine reproductive and respiratory syndrome virus (PRRSV) is due to the response of T cells against the disease, rather than the ...

As respiratory virus season begins, pediatric experts are preparing for an expected rise in cases of Respiratory Syncytial ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today reported financial ...

Researchers recently enhanced the titer of a cell line still in development to produce adenovirus viral vectors by 7.5-fold, and without the risk of also producing replication-competent adenoviruses ...

Chicago’s top health official, Dr. Olusimbo Ige, discusses rising flu, COVID and RSV concerns, urging residents to get vaccinated and take preventive steps as cases begin to climb. Orca vs. great ...